CONTEXT: In lean individuals, increasing dietary lipid can elicit an increase in whole body lipid oxidation; however, with obesity the capacity to respond to changes in substrate availability appears to be compromised. OBJECTIVE: To determine whether the responses of genes regulating lipid oxidation in skeletal muscle differed between lean and insulin resistant obese humans upon exposure to a high-fat diet (HFD). DESIGN AND SETTING: A 5-d prospective study conducted in the research unit of an academic center. PARTICIPANTS: Healthy, lean (n = 12; body mass index = 22.1 ± 0.6 kg/m(2)), and obese (n=10; body mass index = 39.6 ± 1.7 kg/m(2)) males and females, between ages 18 and 30. INTERVENTION: Participants were studied before and after a 5-d HFD (65% fat). MAIN OUTCOME MEASURES: Skeletal muscle biopsies (vastus lateralis) were obtained in the fasted and fed states before and after the HFD and mRNA content for genes involved with lipid oxidation determined. Skeletal muscle acylcarnitine content was determined in the fed states before and after the HFD. RESULTS: Peroxisome proliferator activated receptor (PPAR) α mRNA content increased in lean, but not obese, subjects after a single high-fat meal. From Pre- to Post-HFD, mRNA content exhibited a body size × HFD interaction, where the lean individuals increased while the obese individuals decreased mRNA content for pyruvate dehydrogenase kinase 4, uncoupling protein 3, PPARα, and PPARγ coactivator-1α (P ≤ 0.05). In the obese subjects medium-chain acylcarnitine species tended to accumulate, whereas no change or a reduction was evident in the lean individuals. CONCLUSIONS: These findings indicate a differential response to a lipid stimulus in the skeletal muscle of lean and insulin resistant obese humans.
CONTEXT: In lean individuals, increasing dietary lipid can elicit an increase in whole body lipid oxidation; however, with obesity the capacity to respond to changes in substrate availability appears to be compromised. OBJECTIVE: To determine whether the responses of genes regulating lipid oxidation in skeletal muscle differed between lean and insulin resistant obesehumans upon exposure to a high-fat diet (HFD). DESIGN AND SETTING: A 5-d prospective study conducted in the research unit of an academic center. PARTICIPANTS: Healthy, lean (n = 12; body mass index = 22.1 ± 0.6 kg/m(2)), and obese (n=10; body mass index = 39.6 ± 1.7 kg/m(2)) males and females, between ages 18 and 30. INTERVENTION: Participants were studied before and after a 5-d HFD (65% fat). MAIN OUTCOME MEASURES: Skeletal muscle biopsies (vastus lateralis) were obtained in the fasted and fed states before and after the HFD and mRNA content for genes involved with lipid oxidation determined. Skeletal muscle acylcarnitine content was determined in the fed states before and after the HFD. RESULTS: Peroxisome proliferator activated receptor (PPAR) α mRNA content increased in lean, but not obese, subjects after a single high-fat meal. From Pre- to Post-HFD, mRNA content exhibited a body size × HFD interaction, where the lean individuals increased while the obese individuals decreased mRNA content for pyruvate dehydrogenase kinase 4, uncoupling protein 3, PPARα, and PPARγ coactivator-1α (P ≤ 0.05). In the obese subjects medium-chain acylcarnitine species tended to accumulate, whereas no change or a reduction was evident in the lean individuals. CONCLUSIONS: These findings indicate a differential response to a lipid stimulus in the skeletal muscle of lean and insulin resistant obesehumans.
Authors: Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio Journal: Cell Metab Date: 2008-01 Impact factor: 27.287
Authors: S R Smith; L de Jonge; J J Zachwieja; H Roy; T Nguyen; J C Rood; M M Windhauser; G A Bray Journal: Am J Clin Nutr Date: 2000-02 Impact factor: 7.045
Authors: Barbara Ukropcova; Michele McNeil; Olga Sereda; Lilian de Jonge; Hui Xie; George A Bray; Steven R Smith Journal: J Clin Invest Date: 2005-07 Impact factor: 14.808
Authors: Timothy R Koves; Ping Li; Jie An; Takayuki Akimoto; Dorothy Slentz; Olga Ilkayeva; G Lynis Dohm; Zhen Yan; Christopher B Newgard; Deborah M Muoio Journal: J Biol Chem Date: 2005-08-03 Impact factor: 5.157
Authors: E Bonora; S Kiechl; J Willeit; F Oberhollenzer; G Egger; G Targher; M Alberiche; R C Bonadonna; M Muggeo Journal: Diabetes Date: 1998-10 Impact factor: 9.461
Authors: Mary Elizabeth Baugh; Suzanne M Bowser; Ryan P McMillan; Brenda M Davy; Lauren A Essenmacher; Andrew P Neilson; Matthew W Hulver; Kevin P Davy Journal: J Appl Physiol (1985) Date: 2020-03-12
Authors: Gina M Battaglia; Donghai Zheng; Robert C Hickner; Joseph A Houmard Journal: Am J Physiol Endocrinol Metab Date: 2012-10-09 Impact factor: 4.310
Authors: Sara F Michaliszyn; Lindsey A Sjaarda; Stephanie J Mihalik; Sojung Lee; Fida Bacha; Donald H Chace; Victor R De Jesus; Jerry Vockley; Silva A Arslanian Journal: J Clin Endocrinol Metab Date: 2012-09-13 Impact factor: 5.958
Authors: Jill M Maples; Jeffrey J Brault; Carol A Witczak; Sanghee Park; Monica J Hubal; Todd M Weber; Joseph A Houmard; Brian M Shewchuk Journal: Am J Physiol Endocrinol Metab Date: 2015-06-09 Impact factor: 4.310
Authors: Kim M Huffman; Timothy R Koves; Monica J Hubal; Hiba Abouassi; Nina Beri; Lori A Bateman; Robert D Stevens; Olga R Ilkayeva; Eric P Hoffman; Deborah M Muoio; William E Kraus Journal: Diabetologia Date: 2014-08-05 Impact factor: 10.122